Search Results - "Özalp, Faruk"

Replacement of a Stenotic Quadricuspid Aortic Valve With a Sutureless Prosthesis by Freystaetter, Kathrin, Özalp, Faruk

“…Quadricuspid aortic valve is a rare occurrence, usually presenting with insufficiency rather than stenosis. We report an aortic valve replacement in a…”
Get full text

Profiling inflammation and tissue injury markers in perfusate and bronchoalveolar lavage fluid during human ex vivo lung perfusion by Andreasson, Anders S I, Karamanou, Danai M, Gillespie, Colin S, Özalp, Faruk, Butt, Tanveer, Hill, Paul, Jiwa, Kasim, Walden, Hannah R, Green, Nicola J, Borthwick, Lee A, Clark, Stephen C, Pauli, Henning, Gould, Kate F, Corris, Paul A, Ali, Simi, Dark, John H, Fisher, Andrew J

“…Availability of donor lungs suitable for transplant falls short of current demand and contributes to waiting list mortality. Ex vivo lung perfusion (EVLP)…”
Get full text

Development of de novo aortic valve incompetence in patients with the continuous-flow HeartWare ventricular assist device by Bhagra, Sai, MRCP, Bhagra, Catriona, MD, Özalp, Faruk, MRCS, Butt, Tanveer, FRCS, Ramesh, B.C., FRCS, Parry, Gareth, FRCP, Roysam, Chandrika, FRCA, Woods, Andrew, BSc, Robinson-Smith, Nicola, BA, Wrightson, Neil, BSc, MacGowan, Guy A., MD, Schueler, Stephan, PhD

“…Background In this study we investigated the development of aortic incompetence (AI) and change in aortic root and left ventricular dimensions after…”
Get full text

A Retrospective, Single-Center Study Analyzing Kidney Functions in Sarcoidosis by Alper Alp, Fatma Demirci Üçsular, Faruk Recep Özalp, Hakan Akdam, Sibel Ersan, Mehmet Tanrısev, Enver Yalnız

Get full text

The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma by Arak, Haci, Erkiliç, Suna, Yaslikaya, Şendağ, Eylemer Mocan, Eda, Aktaş, Gökmen, Özdemir, Melek, Semiz, Hüseyin Salih, Kiliçkap, Saadettin, Özalp, Faruk Recep, Sever, Özlem Nuray, Akdağ, Goncagül, Ağaoğlu, Ahmet Burak, Özçelik, Melike, Sari, Murat, Arcagök, Murat, Anik, Hicran, Yayla, Şaziye Burçak, Sever, Nadiye, Açar, Fatma Pinar, Bayrakçi, İsmail, Turhal, Serdar, Ayhan, Murat, Kuş, Tülay

“…Our aim was to assess the efficacy of adjuvant programmed cell death protein-1 (PD-1) inhibitors and compare the other adjuvant treatments in patients with…”
Get full text

The effect of ex vivo lung perfusion on microbial load in human donor lungs by Andreasson, Anders, MD, Karamanou, Danai M., MD, Perry, John D., PhD, Perry, Audrey, MSc, Ӧzalp, Faruk, FRCS, Butt, Tanveer, FRCS, Morley, Katie E., MSc, Walden, Hannah R., PhD, Clark, Stephen C., DM, FRCS, Prabhu, Mahesh, MD, FRCA, Corris, Paul A., FRCP, Gould, Kate, FRCPath, Fisher, Andrew J., PhD, FRCP, Dark, John H., FRCS

“…Background Ex vivo lung perfusion (EVLP) has emerged as a technique to potentially recondition unusable donor lungs for transplantation. Beneficial effects of…”
Get full text

Four-year outcomes with third-generation centrifugal left ventricular assist devices in an era of restricted transplantation by Özalp, Faruk, Bhagra, Sai, Bhagra, Catriona, Butt, Tanveer, Ramesh, Bandigowdanapalya, Robinson-Smith, Nicola, Wrightson, Neil, Parry, Gareth, Griselli, Massimo, Hasan, Asif, Schueler, Stephan, MacGowan, Guy A.

“…OBJECTIVES Third-generation ventricular assist devices (VADs) are associated with improved outcomes, though in recent clinical trials bridge-to-transplant…”
Get full text

Off-pump coronary operations can be safely taught to cardiothoracic trainees by Caputo, Massimo, Chamberlain, Martin H, Özalp, Faruk, Underwood, Malcolm J, Ciulli, Franco, Angelini, Gianni D

“…Background. Off-pump coronary artery bypass (OPCAB) operations are evolving rapidly and becoming established in many cardiothoracic centers. For the technique…”
Get full text

Vascular anastomotic complications in lung transplantation: a single institution's experience by Siddique, Aleem, Bose, Amal K., Özalp, Faruk, Butt, Tanveer A., Muse, Hazel, Morley, Katie E., Dark, John H., Parry, Gareth, Clark, Stephen C.

“…OBJECTIVES Lung transplant recipients were reviewed to compare our early and current experience of vascular complications. Since 1995, we have had a policy of…”
Get full text

An Old Enemy: Still Nephrotoxic by Ozalp, Faruk Recep, Karadeniz, Tugba, Alp, Alper

“…Tubulointerstitial nephritis (TIN) presents histopathologically as tubulitis and oedema/inflammation and fibrosis, affecting the renal tubules and interstitium…”
Get full text

The comparison of functional status and health-related parameters in ovarian cancer survivors with healthy controls by Gultekin, Sukriye Cansu, Cakir, Ahmet Burak, Guc, Zeynep Gulsum, Ozalp, Faruk Recep, Keskinkilic, Merve, Yavuzsen, Tugba, Yavuzsen, Husnu Tore, Karadibak, Didem

“…Purpose The primary purpose of this study was to evaluate functional status and health-related parameters in ovarian cancer (OC) survivors and to compare these…”
Get full text

Off-pump coronary operations can be safely taught to cardiothoracic trainees. Commentary by CAPUTO, Massimo, CHAMBERLAIN, Martin H, ÖZALP, Faruk, UNDERWOOD, Malcolm J, CIULLI, Franco, ANGELINI, Gianni D, PERRAULT, Louis P

Get full text

Informed consent in cardiac surgery: is it truly informed? by Mishra, Pankaj Kumar, Ozalp, Faruk, Gardner, Roy S, Arangannal, Arul, Murday, Andrew

“…OBJECTIVETo develop a validated questionnaire to measure how informed patients are when giving consent for elective coronary artery bypass grafting. METHODSWe…”
Get full text

N-terminal brain natriuretic peptide: The new gold standard in predicting mortality in patients with advanced heart failure by Gardner, Roy S., Ozalp, Faruk, Murday, Andrew J., Robb, Stephen D., McDonagh, Theresa A.

Get full text

A randomized, controlled trial of C0- Vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients by Mathias, Helen C, Ozalp, Farük, Will, Malcolm B, Borland, William, Payne, Carol, Kerr, Myra, Lockhart, Jane, Murday, Andrew J

“…Cyclosporine monitoring using 2-hour post-dose samples (C2) is thought to be more efficacious than using pre-dose levels (C0) in managing immunosuppression for…”
Get more information